AUROLLIS

Glaxo Group Limited

Application Filed: 2011-01-05

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	85210934
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Christopher M. Hanes
Attorney Name	Christopher M. Hanes
Attorney Docket Number	TMR/5075361/
Law Office Assigned	L30
Employee Name	PENDLETON, CAROLYN A

Timeline

2011-01-05	Application Filed
2011-05-03	Published for Opposition
2013-07-22	Location: INTENT TO USE SECTION
2014-08-04	Abandon
2014-08-04	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Glaxo Group Limited
Address	980 Great West Road Brentford, Middles GB TW89GS
Legal Entity Type	Corporation
Legal Entity State	GB

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

CHRISTOPHER M. HANES
GLAXOSMITHKLINE
5 MOORE DR
RESEARCH TRIANGLE PARK, NC 27709-0143

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Type Code

Type

GS0051

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2011-01-08	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2011-01-10	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2011-03-27	3 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2011-03-27	4 CNSA P:
PUBLISHED FOR OPPOSITION	2011-05-03	5 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2011-05-03	6 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2011-06-28	7 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2011-12-16	8 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2011-12-16	9 EXT1 S:
EXTENSION 1 GRANTED	2011-12-16	10 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2011-12-20	11 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2012-06-26	12 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2012-07-19	13 AITU A:Allowance for Publication
EXTENSION 2 FILED	2012-06-26	14 EXT2 S:
EXTENSION 2 GRANTED	2012-07-20	15 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2012-07-21	16 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2012-12-07	17 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2012-12-07	18 EXT3 S:
EXTENSION 3 GRANTED	2013-01-11	19 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-01-12	20 EXRA E:E-Mail
TEAS CHANGE OF OWNER ADDRESS RECEIVED	2013-03-20	21 COAR I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	2013-03-20	22 CHAN I:Incoming Correspondence
TEAS EXTENSION RECEIVED	2013-06-21	23 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2013-07-22	24 AITU A:Allowance for Publication
EXTENSION 4 FILED	2013-06-21	25 EXT4 S:
EXTENSION 4 GRANTED	2013-07-23	26 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-07-24	27 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2013-12-11	28 EEXT I:Incoming Correspondence
EXTENSION 5 FILED	2013-12-11	29 EXT5 S:
EXTENSION 5 GRANTED	2013-12-23	30 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-12-24	31 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2014-08-04	32 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2014-08-04	33 MAB6 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
AUROLLIS 86288773 not registered Dead/Abandoned	Glaxo Group Limited 2014-05-22
AUROLLIS 85210934 not registered Dead/Abandoned	Glaxo Group Limited 2011-01-05
AUROLLIS 77167336 not registered Dead/Abandoned	Glaxo Group Limited 2007-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.